Neurim Pharmaceuticals Ltd.
Records under this name other than the patents Neurim Pharmaceuticals Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Showing 1 to 2 of 2 · Back to Neurim Pharmaceuticals Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,469,044 | Method for treating patients suffering from drug dependencies which lead to plasma melationin deficiencies Term ended Term ended Oct 22, 2019 · From the USPTO record | Term ended | Term ended Oct 22, 2019 | From the USPTO record |
| US 5,750,557 | Method and pharmaceutical formulation for treating benign prostatic hyperplasia Term ended Term ended no later than May 12, 2018 · Low confidence | Term ended | Term ended no later than May 12, 2018 | Low confidence |